Benchling Validated Cloud Enables GxP Migration

Validated Cloud turns Benchling from a tool for research teams into a system that can follow a drug program into regulated development and manufacturing. The key shift is that customers no longer need one stack for discovery and another for GxP work. They can keep experiments, sample records, approvals, and handoffs in one controlled environment with audit trails, e-signatures, validation support, and quarterly managed releases, which cuts rework during tech transfer and reduces the burden on internal IT teams.

• For teams replacing homegrown software, the hard part is not just storing data. It is proving who changed what, who signed off, and whether the system stayed in a known state over time. Benchling packages those controls into a dedicated validated tenant with validation documentation and risk assessments, which is what internal tools often struggle to maintain.
  1 benchling 3 benchling 4 benchling
• This also expands contract size. Benchling already sells seats, modules, and services, with services attached to every deal and larger rollouts sometimes lasting 18 months. Validated Cloud gives Benchling a clear upsell path as a customer moves from early research into preclinical, clinical, and manufacturing workflows.
  2 sacra 5 benchling
• The competitive angle is that many legacy life sciences systems are still on premise, modular, and hard to change. Benchling is selling a cloud system that still offers the controls regulated teams need, which makes it more attractive to companies trying to modernize without taking on a custom validation project themselves.
  2 sacra 6 sacra

Going forward, Validated Cloud is the bridge that lets Benchling move upmarket from lab software into core regulated infrastructure. As more biopharma companies standardize on one system from research through manufacturing, Benchling should capture more users, more workflows, and more of the budget that used to sit with internal informatics teams and legacy vendors.